In HCC, Resveratrol inhibits mito-COX-2 acetylation, leading to a decrease in cell proliferation and mitochondrial fission, which occurs through up-regulation of SIRT3 226. The gene discussed is SIRT3; the disease is hepatocellular carcinoma.